THE Portugal temporarily suspended its use AstraZeneca vaccine COVID-19, as well as several other European countries amid concerns about possible side effects.
Earlier, Spain, France, Germany and Italy followed the example of Denmark, Norway and several others by suspending the use of the vaccine following reports of blood clots in some patients who had received the vaccine.
Grassa Freitas, head of the DGS health service, told a news conference that although the side effects were “extremely serious”, they were “extremely rare” and added that no similar cases had been reported in Portugal so far.
Portugal, which has recorded 814,513 infections and 16,694 deaths, has so far given about 1.1 million doses of vaccine, with the majority of vaccines being those produced by Pfizer-BioNTech.
Enrique Guveia e Melo, head of the Portuguese vaccination task force, said the AstraZeneca vaccines that have so far arrived in Portugal would remain in storage until further notice.
About 400,000 doses of the vaccine have been given so far and there is a stock of another 200,000, he said.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
